The global neurorehabilitation devices market is anticipated to grow at a CAGR of 13.9% during the forecast period (2023-2030). The neuro-robotic devices segment is anticipated significant growth in the neurorehabilitation devices market. It is projected to exhibit a similar trend over the course of the projection period owing to the rising prevalence of neurological disorders, advances in robotics and their integration with neuroscience, as well as the release of novel products. Robotic devices for neurorehabilitation can be divided into two main categories based on the different types of physical human-robot interactions, such as end-effector devices and exoskeletons.
Browse the full report description of “Neurorehabilitation Devices Market Size, Share & Trends Analysis Report by Product (Neurorobotics, Brain-Computer Interface and Non-Invasive Stimulators), by Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy and Others), and by End User (Rehabilitation Centers and Hospitals and Clinics), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/neurorehabilitation-devices-market
Another factor propelling the adoption of devices and subsequent industry expansion is research studies aimed at evaluating the efficacy of the robotic approach in neurorehabilitation. Thus, the rising prevalence of neurological disorders, the benefits associated with neuro-robotic devices, the establishment of robotic-assisted neurorehabilitation centers, and technological advancements are the key driving factors in the neuro-robotic devices segment. According to the Alzheimer's Association, in 2022, an estimated 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia in 2023. 72% are age 75 or older. Of the total US population, about 1 in 9 people (10.8%) age 65 and older has Alzheimer’s dementia. The percentage of people with Alzheimer’s dementia increases with age: 5.0% of people aged 65 to 74, 13.1% of people aged 75 to 84, and 33.3% of people aged 85 and older have Alzheimer’s dementia.
Additionally, the establishment of new robotic-assisted neurorehabilitation centers improved the accessibility of neuro-robotic devices and is thus expected to contribute to segment growth. For instance, in December 2021, Sakra World Hospital, a healthcare organization, launched a robotic-assisted neuro-rehabilitation center in Bangalore, the first ever in Karnataka. Sakra Rehabilitation is the most reputable advanced rehabilitation institution, providing Prehab and Rehab as Inpatient, Outpatient, and Home-based Tele-Rehabilitation.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Therapy Area
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- includes Bioventus LLC, Ectron Corp., Hocoma AG, Medtronic Plc, and Tyromotion GmbH, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Neurorehabilitation Devices Market Report Segment
By Product
By Therapy Area
By End-User
Global Neurorehabilitation Devices Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neurorehabilitation-devices-market